Göllner, S., & Müller-Tidow, C. (2017). Inhibition of EZH2 degradation as a novel approach to overcome drug resistance in acute myeloid leukemia. Molecular & cellular oncology, 4(2), . https://doi.org/10.1080/23723556.2017.1291396
Chicago-Zitierstil (17. Ausg.)Göllner, Stefanie, und Carsten Müller-Tidow. "Inhibition of EZH2 Degradation as a Novel Approach to Overcome Drug Resistance in Acute Myeloid Leukemia." Molecular & Cellular Oncology 4, no. 2 (2017). https://doi.org/10.1080/23723556.2017.1291396.
MLA-Zitierstil (9. Ausg.)Göllner, Stefanie, und Carsten Müller-Tidow. "Inhibition of EZH2 Degradation as a Novel Approach to Overcome Drug Resistance in Acute Myeloid Leukemia." Molecular & Cellular Oncology, vol. 4, no. 2, 2017, https://doi.org/10.1080/23723556.2017.1291396.